olpadronic acid has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boland, R; Pérez-Lloret, A; Roldán, E; Santillan, G; Vazquez, G | 1 |
| Keppler, BK; Klenner, T; Krempien, B; Schmähl, D; Wingen, F | 1 |
2 other study(ies) available for olpadronic acid and Osteogenic Sarcoma
| Article | Year |
|---|---|
Modulation of cytosolic calcium levels in osteoblast-like osteosarcoma cells by olpadronate and its amino-derivative IG-9402.
Topics: Animals; Calcitriol; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Chick Embryo; Cytosol; Diphosphonates; Dose-Response Relationship, Drug; Estrenes; Neomycin; Nifedipine; Osteoblasts; Osteocalcin; Osteosarcoma; Pyrrolidinones; Rats; Thapsigargin; Tumor Cells, Cultured; Type C Phospholipases; Verapamil | 2003 |
Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?
Topics: Animals; Bone and Bones; Bone Neoplasms; Carcinoma 256, Walker; Diphosphonates; Drug Evaluation, Preclinical; Organophosphorus Compounds; Organoplatinum Compounds; Osteosarcoma; Pamidronate; Rats | 1990 |